A. Vouillaume

Honeywell (France)

Papers

1

Total Citations

41

H-Index

1

About

Dr. A. Vouillaume has made significant contributions to the field of radiation oncology, with a particular focus on advancing stereotactic body radiation therapy (SBRT) through precise image-guided techniques. Their key research areas include fiducial marker implantation, robotic radiosurgery, and treatment toxicity assessment. In their most cited work (2019, 41 citations), Dr. Vouillaume conducted a pivotal retrospective study evaluating the safety and efficacy of fiducial marker tracking for CyberKnife® SBRT in extracranial sites. This research demonstrated the feasibility and low toxicity of this approach, providing critical evidence for the clinical implementation of real-time tumor tracking in robotic SBRT. By systematically assessing implantation outcomes, Dr. Vouillaume helped establish best practices for fiducial placement that enhance treatment accuracy for moving tumors. Their work has directly impacted clinical protocols, enabling more precise radiation delivery while minimizing damage to surrounding healthy tissue. This study remains a foundational reference for practitioners adopting fiducial-based tracking systems, underscoring Dr. Vouillaume’s role in bridging technological innovation with practical patient care in modern radiotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
41 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Honeywell (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago